Receives

March 29, 2017

MMJ PhytoTech Ltd (ASX:MMJ) Australian Distribution Partner Receives Medicinal Cannabis

Satipharm intends to make Gelpell capsules with THC and THC/CBD formulations available to the Australian market once the necessary regulatory ……

Read More

March 20, 2017

ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis

The Cannabis Provisional Patent #62466209, a patent for delivering … Also, a patent application using the combination of CBD and THC with…

Read More

March 16, 2017

CPH's subsidiary Hemp Industries receives approval to sell new range of hemp extract products in …

Creso Pharma has established itself as a leader in cannabidiol innovation, and is developing cannabis and hemp derived therapeutic grade CBD ……

Read More

February 28, 2017

Autism Approval: Medical Marijuana, Inc. Subsidiary HempMedsĀ® Brasil Receives Brazilian …

Earlier this month, Medical Marijuana, Inc. also announced that ANVISA had … focusing on CBD's effects on behavioral symptoms associated with autism."…

Read More

February 22, 2017

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMedsĀ® Brasil Receives …

… doctor's prescription for the Company's hemp cannabidiol (CBD) oil product … HempMeds Brasil currently has three cannabis products approved for ……

Read More

January 10, 2017

Medical Marijuna, Inc. Investment AXIM(R) Biotech Receives Positive PK Data Results for …

The single dose study on 10 mg of cannabidiol (CBD) and 30 mg of CBD … Our mission is to be the…

Read More

January 5, 2017

Medical Marijuana Inc (OTCMKTS:MJNA) Receives Coverage From L.A. Weekly

Medical Marijuana Inc (OTCMKTS:MJNA) closed at a share price of $0.148, at the end of the January 5 trading … products allowed…

Read More

Medical Marijuana Inc (OTCMKTS:MJNA) Receives Coverage From L.A. Weekly

The story also highlighted how the company collaborated with families of potential patients and their attorney's, to develop a CBD oil product,…

Read More

December 21, 2016

Vitality Biopharma Receives DEA Approval for Cannabinoid Pharma Development Facility

As a component of this process, Vitality's preclinical studies for its proprietary prodrugs of CBD and THC were reviewed and approved by…

Read More